ARDS Clinical Trials

115 recruitingLast updated: June 18, 2026

There are 115 actively recruiting ards clinical trials across 33 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Durham, North Carolina, United States. Updated daily from ClinicalTrials.gov.


ARDS Trials at a Glance

115 actively recruiting trials for ards are listed on ClinicalTrialsFinder across 6 cities in 33 countries. The largest study group is Not Applicable with 49 trials, with the heaviest enrollment activity in New York, Houston, and Durham. Lead sponsors running ards studies include Assistance Publique - Hôpitaux de Paris, PPD Development, LP, and Southeast University, China.

Browse ards trials by phase

Treatments under study

About ARDS Clinical Trials

Looking for clinical trials for ARDS? There are currently 34 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ARDS trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ARDS clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 115 trials

Recruiting

Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)

Urinary Tract InfectionsAntiobiotic StewardshipEmerging Infectious Disease
Centre Hospitalier Intercommunal Creteil330 enrolled3 locationsNCT07559318
Recruiting
Early Phase 1

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

ARDS (Moderate or Severe)ARDS (Acute Respiratory Distress Syndrome)
Shanghai Zhongshan Hospital24 enrolled1 locationNCT07558538
Recruiting

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

ARDS (Acute Respiratory Distress Syndrome)
University of Pennsylvania36 enrolled1 locationNCT07125079
Recruiting

Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation

Validation Study of Molecular Diagnostic SystemDevelopment of Reporting System for Molecular DiagnosisIncorporate Molecular Diagnosis Into Diagnostic Standards
University of Alberta500 enrolled26 locationsNCT01299168
Recruiting
Not Applicable

Titration of Positive End-expiratory Pressure: Comparison Between Manual Thoracic or Abdominal Compression and Electrical Impedance Tomography

ARDS (Acute Respiratory Distress Syndrome)
Centre Hospitalier Saint Joseph Saint Luc de Lyon30 enrolled2 locationsNCT07623590
Recruiting

Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.

Acute Respiratory Distress Syndrome (ARDS)
Centre Hospitalier de la côte Basque30 enrolled1 locationNCT07090460
Recruiting
Phase 3

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals300 enrolled6 locationsNCT07498426
Recruiting
Not Applicable

Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome

ARDS, HumanMechanical VentilationLung Ultrasound
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)538 enrolled10 locationsNCT05492344
Recruiting
Phase 1

Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS

ARDS (Acute Respiratory Distress Syndrome)
HTIC, Inc24 enrolled2 locationsNCT07449572
Recruiting
Not Applicable

Effect of EIT-guided PEEP in ARDS Patients

ARDS (Acute Respiratory Distress Syndrome)
Southeast University, China2,400 enrolled3 locationsNCT06990477
Recruiting

Study of the Immunological Pathophysiological Mechanisms Associated With Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome (ARDS)
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT07395076
Recruiting
Phase 3

RECOMMEND Platform Trial

Intensive Care MedicineCritical IllnessCardiac Arrest (CA)+2 more
Australian and New Zealand Intensive Care Research Centre600 enrolled3 locationsNCT06526533
Recruiting
Not Applicable

Optimal Implementation of Antimicrobial Stewardship in General Practice

Respiratory Tract Infections (RTI)The Use of Antimicrobial Stewardship in in General Practice (Family Medicine)
University of Wollongong120 enrolled4 locationsNCT06953804
Recruiting
Phase 2

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP200 enrolled40 locationsNCT06701669
Recruiting
Phase 2

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP200 enrolled40 locationsNCT06701656
Recruiting
Phase 2

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP200 enrolled40 locationsNCT06701682
Recruiting
Phase 2

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP600 enrolled40 locationsNCT06703073
Recruiting
Phase 3

Pirfenidone to Prevent Fibrosis in Ards.

Acute Respiratory Distress Syndrome (ARDS)
Università Vita-Salute San Raffaele130 enrolled17 locationsNCT05075161
Recruiting
Not Applicable

Engaging Mental Effort: Process- and Person-Based Reward Experiences, Effort Reinforcement Intervention, and Cascading Effects on Challenging Tasks

Performance vs. Effort Rewards
University of California, Davis180 enrolled1 locationNCT07557732
Recruiting
Not Applicable

Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study.

ARDS, HumanObesity, Morbid
Assistance Publique - Hôpitaux de Paris40 enrolled5 locationsNCT06119516